Kazuko Horiuchi Suzuki

Title: Kazuko Horiuchi Suzuki: Innovator in Diagnostic Imaging for Cancer Therapy

Introduction

Kazuko Horiuchi Suzuki is a prominent inventor based in Kyoto, Japan. She has made significant contributions to the field of medical imaging, particularly in the diagnosis and treatment of cancerous bone metastasis. Her innovative work has the potential to improve patient outcomes through more accurate therapy selection.

Latest Patents

Kazuko Horiuchi Suzuki holds a patent for a diagnostic imaging agent that is useful for selecting therapy for cancerous bone metastasis. The patent describes a diagnostic imaging agent that comprises Tc(V)-dimercaptosuccinic acid as an effective ingredient. This agent is administered to patients, allowing for the creation of a scintigram. It is particularly beneficial for identifying osteoclastic type or mixed type bone metastasis, as well as diseases characterized by enhanced bone resorption due to osteoclast activity. This innovation facilitates the proper selection of therapies for such conditions.

Career Highlights

Kazuko Horiuchi Suzuki is associated with Nihon Medi-Physics Company, Limited, where she continues to advance her research and development efforts. Her work has garnered attention in the medical community for its potential to enhance diagnostic accuracy and treatment efficacy.

Collaborations

Kazuko has collaborated with notable colleagues, including Akira Yokoyama and Hideo Saji. These partnerships have contributed to the development and refinement of her innovative diagnostic imaging techniques.

Conclusion

Kazuko Horiuchi Suzuki's contributions to the field of diagnostic imaging represent a significant advancement in cancer therapy selection. Her innovative patent and collaborative efforts highlight her commitment to improving patient care through technology.